Early evidence of the efficacy of TCR-T therapy targeting the G12V mutation in patients with advanced pancreatic cancer.
Saved in:
| Title: | Early evidence of the efficacy of TCR-T therapy targeting the G12V mutation in patients with advanced pancreatic cancer. |
|---|---|
| Authors: | Hu HM; Shanghai ImmunXell, Ltd., Shanghai, China. Electronic address: hmhu@immuxell.com., Han Y; Shanghai ImmunXell, Ltd., Shanghai, China., Li Y; Sun Yat-sen University Cancer Center, Guangzhou, China. |
| Source: | Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2026 Jun 22. Date of Electronic Publication: 2026 Jun 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1525-0024 |
|---|---|
| DOI: | 10.1016/j.ymthe.2026.06.010 |
